Answer
The mean terminal half-life of NovoSeven (eptacog alfa) ranged from 3.9 to 6.0 hours in a dose-escalation study of 35 healthy Caucasian and Japanese subjects.
Sources for this answer
- NovoSeven 2mg (100 KIU) powder and solvent for solution for injectionNovo Nordisk Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 2Document updated
Sources checked